The Trader Harbor
  • Business
  • Politics
  • World News
  • Stocks
  • Business
  • Politics
  • World News
  • Stocks

The Trader Harbor

Politics

Former Biden doctor asks to delay testimony to House committee investigating mental fitness

by admin July 8, 2025
July 8, 2025
Former Biden doctor asks to delay testimony to House committee investigating mental fitness

Former White House physician Kevin O’Connor, who served as doctor to former President Joe Biden, requested a delay to his upcoming testimony before the House Oversight Committee this week.

O’Connor was scheduled to testify on Wednesday, but is now in a disagreement with the committee over the scope of the questions he will be expected to answer during his testimony. The committee, led by Chairman James Comer, R-Ky., is interviewing the doctor as part of its investigation into Biden’s mental fitness and his administration’s use of an autopen.

A lawyer for O’Connor requested the testimony be delayed to July 28 or August 4 in a letter to Comer.

‘Dr. O’Connor has legal and ethical obligations that he must satisfy and for which violations carry serious consequences to him professionally and personally,’ the letter says.

‘We are unaware of any prior occasion on which a Congressional Committee has subpoenaed a physician to testify about the treatment of an individual patient.  And the notion that a Congressional Committee would do so without any regard whatsoever for the confidentiality of the physician-patient relationship is alarming.’

A spokesman for the Oversight Committee replied in a statement that O’Connor and his legal team were merely trying to ‘stonewall’ the process. The committee is planning to move forward with Wednesday’s testimony, which O’Connor faces a subpoena to attend.

The committee said O’Connor is welcome to object to individual questions during his testimony. But O’Connor is not allowed, in the committee’s view, to delay or decline a congressional subpoena due to concerns over questions about potentially privileged information.

The debate over O’Connor’s testimony comes weeks after a former top aide to Biden, Neera Tanden, told the Oversight Committee that she was authorized to direct autopen signatures but was unaware of who in the president’s inner circle was giving her final clearance.

During Tanden’s interview before Congress last month, which lasted more than five hours, she told lawmakers that, in her role as staff secretary and senior advisor to the former president between 2021 and 2023, she was authorized to direct autopen signatures on behalf of Biden, an Oversight Committee official told Fox News.

‘Ms. Tanden testified that she had minimal interaction with President Biden, despite wielding tremendous authority,’ Comer said at the time. ‘She explained that to obtain approval for autopen signatures, she would send decision memos to members of the President’s inner circle and had no visibility of what occurred between sending the memo and receiving it back with approval. Her testimony raises serious questions about who was really calling the shots in the Biden White House amid the President’s obvious decline. We will continue to pursue the truth for the American people.’

Fox News’ Kelly Phares and Madeleine Rivera and the Associated Press contributed to this report.

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Is a Chinese chain’s blood orange cold brew the future of coffee in America?
next post
Key advisor called Hunter Biden’s role on strategy call ‘inappropriate’ after he overruled legal guidance

Related Posts

3 numbers that explain November election results –...

December 6, 2024

Dems lose it over GOP plan to rename...

April 4, 2024

Speaker Johnson pushes ‘decorum’ after AOC, Marjorie Taylor...

May 18, 2024

‘Fully justified’: Graham plows ahead with Trump border...

June 13, 2025

Trump has the opportunity to stop Iran from...

March 14, 2025

Zelenskyy wants details after Trump-Putin call, lays out...

March 19, 2025

Judge tells government watchdogs fired by Trump there’s...

March 28, 2025

Pelosi confident about Dems’ chances to win House,...

July 26, 2025

UN prepping for spending cuts as DOGE roots...

March 7, 2025

5 mistakes that doomed Kamala Harris’ campaign against...

November 8, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Union Pacific to buy Norfolk in $85 billion mega U.S. railroad deal

      July 30, 2025
    • The Real Drivers of This Market: AI, Semis & Robotics

      July 30, 2025
    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

      July 30, 2025
    • Mamdani’s rise, ‘vile hatred’ of US Jews the focus of ‘critical’ closed-door congressional huddle

      July 30, 2025
    • Gaza Humanitarian Foundation: What to know about the US-backed aid group

      July 30, 2025
    • Starmer says UK to recognize Palestinian state if Israel doesn’t agree to ceasefire, Hamas must ‘disarm’

      July 30, 2025

    Categories

    • Business (1,313)
    • Politics (4,122)
    • Stocks (1,555)
    • Uncategorized (45)
    • World News (1,306)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheTraderHarbor, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thetraderharbor.com | All Rights Reserved